📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The intracellular signalling pathway signature (the signalome) in PBMCs in the presence of a common TRAPS-associated genetic variant, TNFRSF1A p.(Arg121Gln) (legacy p.R92Q) is distinct from normal PBMCs and from other pathogenic variants (2015)

First Author: Bybee A

Attributed to: Development of a high-content intracellular signalling pathway analysis methodology for drug repurposing funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/1546-0096-13-s1-p19

Publication URI: http://dx.doi.org/10.1186/1546-0096-13-s1-p19

Type: Journal Article/Review

Parent Publication: Pediatric Rheumatology

Issue: S1